Table 1. The amounts of CS in condition medium of siRNA-treated colon fibroblasts.

	pmol/mg protein (mol%)
	Negative control siRNA	CHST15 siRNA
ΔHexUA-GalNAc	314 ± 40 (2.6 ± 0.3)	441 ± 47 (3.7 ± 0.4)
ΔHexUA-GalNAc(6S)	2,780 ± 189 (22.8 ± 0.8)	2,640 ± 122 (21.5 ± 0.7)
ΔHexUA-GalNAc(4S)	8,045 ± 189 (66.2 ± 0.9)	8,542 ± 97 (69.8 ± 0.3)
ΔHexUA(2S)-GalNAc(6S)	226 ± 15 (1.9 ± 0.1)	230 ±13 (1.8 ± 0.1)
ΔHexUA(2S)-GalNAc(4S)	128 ± 21 (1.0 ± 0.2)	196 ± 27 (1.6 ± 0.2)
ΔHexUA-GalNAc(4S,6S)	672 ± 57 (5.5 ± 0.3)	196 ± 6 (1.6 ± 0.1)
Total CS disaccharide	12,165 ± 419 (100)	12,244 ± 173 (100)